{"disease":{"id":"stage-iii-nasopharyngeal-keratinizing-squamous-cell-carcinoma-ajcc-v7","name":"stage iii nasopharyngeal keratinizing squamous cell carcinoma ajcc v7"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00274937","title":"Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT00408694","title":"Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}